Urokinase Product Approval Information - New Drug Application 10/10/02

Product name: Urokinase (Abbokinase)
Manufacturer: Abbott Laboratories, Abbott Park, IL
Intended Use: for adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments, and for the lysis of pulmonary emboli accompanied by unstable hemodynamics, i.e., failure to maintain blood pressure without supportive measures
Approval Date: 10/10/2002
Type of submission: New Drug application supplement


Approval Letter - (PDF)

Label - (PDF) 


Other Information on Urokinase


Page Last Updated: 05/06/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English